Nycrist Pharmatech Limited researches and develops preclinical drugs, including solid, oral film, and topical preparations.
Established in 2015 and based in Shenzhen, China, Nycrist Pharmatech Limited focuses on research and development of preclinical drugs. Its platform includes a research and development facility and production line of more than 6,000 square meters, with laboratories for crystal drug research and new drug development. Its products include solid, oral film, and topical preparations used in conditions such as schizophrenia, skin infections, and leukemia. In July 2018 the firm closed an angel funding round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in